![]() |
|
|
Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA 94720-3104
3To whom correspondence should be addressed. E-mail: fleming{at}nature.berkeley.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: cholesterol sterols fatty acids
The epithelial cells of the colonic mucosa function as a barrier between luminal bacteria and the rest of the body, and as transporters of certain ions, water and SCFA. The maintenance of barrier and the transporter functions depend on the proper assembly of cell membranes, which require cholesterol and phospholipid. Like other rapidly dividing cells (e.g., lymphocytes, thymocytes or tumor cells), colonic mucosal cells have a greater need for cholesterol and phospholipid than slowly dividing cells. This need for lipids can be met by de novo synthesis or by removal of cholesterol and fatty acids from the bloodstream. Although colonic epithelial cells possess LDL receptors, endogenous synthesis supplies the majority of the cellular cholesterol needs, and the uptake of LDL cholesterol is quantitatively less important and essentially constant (1). Although butyrate has been shown to provide some of the acetyl-CoA (AcCoA)3 needed for de novo lipogenesis, it was not known whether butyrate was essential or the preferred substrate for this function.
Factors that affect synthesis of cholesterol and fatty acids have been shown to influence proliferation of colonic cells and risk of colonic tumorigenesis. Using cultured human adenocarcinoma cells, cell proliferation was reduced by blocking the cholesterol synthetic pathway using inhibitors of the regulatory enzyme, hydroxymethyl glutaryl (HMG)-CoA reductase (24). In mice, inhibitors of HMG-CoA reductase reduced colonic tumorigenesis (5), and this reduction appeared to be related to suppression of colonic mucosal cholesterol rather than plasma cholesterol (6,7). Conversely, feeding dietary cholesterol increased cell proliferation and risk of colonic tumorigenesis (8,9).
Very little is known about de novo lipogenesis in colonic epithelial cells even though it has been known for some time that colonic tissue is metabolically capable of synthesizing lipids (10,11). Roediger (12) was the first investigator to provide direct evidence for cholesterol and fatty acid synthesis in the epithelial cells of the colon. Carbon atoms from butyrate are incorporated into lipids of rat colonocytes (12) and HT29 cultured human adenocarcinoma cells (13). In these earlier studies, glucose was shown to stimulate lipid synthesis (12,13). Butyrate was shown also to influence lipid metabolism in Caco2 cells (14,15). Whether butyrate is the primary source of synthetic precursors for fatty acid and cholesterol synthesis by nontransformed colonic epithelial cells is unknown.
The primary goal of the present study was to determine which substrates contribute carbon atoms for the synthesis of fatty acids and cholesterol by primary colonic epithelial cells, and the relative contribution of major substrates to the synthetic precursor pools. In this study, substrates including the SCFA, acetate, propionate and butyrate, along with glucose, glutamine and ketone bodies were studied. Colonocytes preferentially metabolize lumenal compared with serosal substrates (1618). The SCFA produced by the bacterial fermentation of undigested carbohydrate are the major lumenal substrates available to the colonocytes. Butyrate is utilized to a greater extent than acetate and propionate and is the preferred oxidative fuel of the colonic epithelial cell (1719). If the metabolic pathways and pools used to synthesize lipids were the same as those used to produce CO2 and ketone bodies, we would expect butyrate to make the greatest carbon contribution to cholesterol and fatty acids in isolated colonocytes. Because butyrate oxidation to CO2 was not suppressed by the presence of alternative fuels in our earlier studies, we would expect also that butyrate incorporation into lipids would not be influenced by the presence of other substrates. The results of our initial lipogenesis experiments suggested otherwise. Thus, the second goal of the current studies was to attain insight into the pathways by which SCFA are metabolized and transported into the precursor pools for lipid synthesis in colonic epithelial cells.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Male Fisher 344 rats (National Institute on Aging breeding colony, Harlan Industries, Indianapolis, IN) weighing 240400 g were used. Rats were fed a purchased (Western Research Products, Hayward, CA) NIH 31 stock diet (20). All rats had free access to food and water. Rats were housed at 25°C with a 12-h light:dark cycle. The Animal Care and Use Committee, University of California, Berkeley, approved all rat handling procedures.
Chemicals.
Radiochemicals were obtained commercially and included [2-14C]propionate, [U-14C]glutamine, [1-14C]-3-hydroxybutyrate, [1,5-14C]citrate, [3H]H2O (American Radiolabeled Chemicals, St. Louis, MO); [2-14C]acetate, [U-14C]glucose, [4-14C]cholesterol (DuPont NEN, Boston, MA); [U-14C]acetate, [1-14C]palmitate, [1-14C]butyrate (ARC; DuPont) and [1-14C]acetate (ARC; ICN Pharmaceuticals, Costa Mesa, CA). Before use, radioactive tracers were chromatographed via TLC and purified. (-)-Hydroxycitrate (lactone form) was a generous gift from Dr. J. Sepinwall at Hoffmann-LaRoche, Nutley, NJ. The lactone was hydrolyzed to the acid form (21), and the presence of the acid form was confirmed by TLC (22). All other chemicals and reagents were obtained commercially and were reagent grade.
Preparation of isolated cells.
On the day of the experiment, rats were anesthetized by an intraperitoneal injection of Nembutal (Abbott Laboratories, North Chicago, IL) at 5 mg/100 g body weight and killed by heart puncture. The entire colon was removed from the ceco-colonic junction to the distal anal canal. The method for removing the epithelial cells was described previously (23). Lactate dehydrogenase (LDH; EC 1.1.1.27) release was used to evaluate membrane integrity (23). Leakage of LDH into the medium was 11.7 ± 0.8% over the ensuing 60 min (mean ± SEM, n = 27). Data are reported on a dry-weight (dry wt) basis as previously described (23).
Selection of substrates and their concentrations.
The choice of substrates was based on previous data showing that isolated colonic epithelial cells are capable of activating and oxidizing to CO2 substrates including acetate, propionate, butyrate, glucose, glutamine and ketone bodies (2427). In those experiments, the apparent Km for substrate oxidation was reported to be <1 mmol/L (2628) and substrate concentrations
5 mmol/L saturated the oxidative pathways with substrate carbon. In these studies, substrate concentrations ranged from 5 to 15 mmol/L. In vivo, butyrate concentrations in cecal fluid and colonic contents of rats, pigs and monkeys were reported to be as low as 37 mmol/L when diets containing little or no fermentable dietary fiber were fed, and as high as 40 mmol/L when diets provided ample fermentable fiber (29). In vivo concentrations were reported to vary widely also for propionate (545 mmol/L) and acetate (15380 mmol/L) (29). Glucose and glutamine are most likely to be provided to colonocytes via the arterial blood supply; under fasting conditions, these averaged 4 and 0.5 mmol/L, respectively (30). Ketone bodies, also available to colonocytes via the arterial blood supply during fasting, are largely dependent on the duration of the fast and, in healthy humans, may range from 1 to 8 mmol/L.
Carbon dioxide production.
Aliquots of cell suspension (1 mL) were mixed with Krebs-Henseleit buffer containing 14C-labeled and unlabeled substrate, incubated and CO2 collected as previously described (19). Carbon dioxide production from 14C-butyrate in 5 mmol/L butyrate was measured (19) to ensure normal cellular metabolism, and was 5.60 ± 0.3 µmol CO2/(g dry wt · min) (mean ± SEM), which is similar to values reported previously.
Inhibition of citrate lyase by (-)-hydroxycitrate.
(-)-Hydroxycitrate is a powerful inhibitor of the enzyme ATP-citrate lyase (31), which catalyzes the cytosolic cleavage of citrate to form oxaloacetate and AcCoA. The acid has also been shown to be an effective inhibitor of fatty acid (21,3234) and cholesterol synthesis (3537) in nonintestinal tissues. Citrate lyase was assayed using the method of Srere (38).
Lipid synthesis assay.
Aliquots of cell suspension (1 mL, 48 g dry weight/L for 14C assays, 1520 g dry weight/L for 3H2O assays) and incubating media (1 mL) were added in duplicate to 25-mL Erlenmeyer flasks. The incubating media consisted of 14C-labeled substrate (1040 kBq/µmol) or 3H2O (300 mBq/flask) and unlabeled substrates in KH buffer with antibiotics as previously described (19). Flasks were gassed with O2/CO2 (19:1, v/v) and sealed with double-seal stoppers. Incubations were performed for 60 min at 37°C in a shaking water bath. After the incubation, reactions were stopped by adding 2 mL methanol.
There were no significant differences in 14C incorporation into sterols or fatty acids when [U-14C]acetate, [1-14C]acetate and [2-14C]acetate were used as tracers (data not shown), indicating that the isotopes could be used interchangeably. Nonetheless, [1-14C]acetate was used in all experiments.
Lipid extraction and separation.
Lipids were extracted from the cells with methanol and chloroform according to the method of Bligh and Dyer (39) with modifications by Levin (40). The extracted lipids were applied to TLC plates (20 x 20 cm silica gel GF, Alltech, Deerfield, IL), developed in petroleum ether/ethyl ether/glacial acetic acid (80:20:1), and visualized by spraying with dichlorofluorescein (Sigma, St. Louis, MO). The bands corresponding to cholesterol, lanosterol, phospholipid, free fatty acids (FFA) and triacylglyceride (TAG) standards were scraped from the plate and incubated for 1 h at 40°C in 1 mL of TS-2 tissue solubilizer (Research Products International, Mount Prospect, IL). These bands accounted for >95% of the radioactivity in the lanes for all experiments. At the end of the incubation, 15 mL of 3a70b scintillation cocktail (Research Products International) and 0.105 mL of glacial acetic acid (decrease chemiluminescence) were added to the lipid sample, which was counted using a scintillation counter (Packard, Meridan, CT). When samples were not saponified, incomplete resolution of the cholesterol and phospholipid bands precluded quantitative separation of these two species. For this reason, incorporation values into sterols under nonsaponified conditions were not reported. In all other experiments, radioactivity in total sterols was calculated as the sum of radioactivity in the free cholesterol and lanosterol bands.
In the experiments that measured incorporation into fatty acids [sum of fatty acids present as FFA, in phospholipids (PL) and in TAG], the chloroform extract was saponified in 0.2 mL of 30% alcoholic KOH overnight at room temperature. After saponification, 0.8 mL of water was added and the mixture was acidified with H2SO4 (9 mol/L). The lipids were extracted with petroleum ether (3 x 3 mL), blown to dryness under a stream of N2 and dissolved in chloroform. The lipids were applied to TLC plates and processed as described above.
Recovery of cholesterol and fatty acids was determined in duplicate by adding a known amount of [4-14C]cholesterol and [1-14C]palmitate to cell suspension. The incorporation values obtained in the treatment flasks were corrected for any losses in recovery. The values for cholesterol and palmitate recovery were very consistent from flask to flask and day to day.
Calculations.
The incorporation of 3H2O into lipids was converted from Bq/min to µmol by dividing by the specific activity (Bq/µmol) of the substrate using Eq. (1).
![]() | (1) |
![]() |
Tritiated water incorporation data are reported as µmol 3H2O/(g dry wt · h).
The incorporation of 14C-substrates into lipids was converted from Bq to nmol by dividing by the specific activity (Bq/µmol) of the substrate using Eq. (2).
![]() | (2) |
![]() |
14C-Substrate incorporation data are reported as nmol substrate carbon/(g dry wt · h). The recovery of cholesterol and palmitate was 85.3 ± 0.8 and 82.5 ± 1.3% (means ± SEM, n = 26), respectively. To calculate the results as nmol substrate carbon, it was necessary to convert the result from Eq. (2) into nmol AcCoA carbon incorporated followed by conversion to nmol substrate carbon.
To calculate substrate incorporation into fatty acids, values determined in Eq. (2) were multiplied by the number of carbons in the substrate that could be incorporated into fatty acids. Because none of the carbons of acetate, butyrate and 3-hydroxybutyrate are lost in their incorporation into fatty acids, the value determined in Eq. (2) was multiplied by 2, 4 and 4, respectively. The incorporation of propionate, glucose and glutamine into fatty acids results in the loss of some carbons as CO2; thus the value determined in Eq. (2) was multiplied by 2, 4 and 2, respectively.
To calculate nmol carbon incorporated into sterols from nmol substrate, it was necessary to first convert to nmol AcCoA incorporated to correct for the unequal losses of the number one and two carbons of AcCoA in the cholesterol synthetic pathway. When the radioactive label was on the number one carbon, Eq. (3) was used.
![]() | (3) |
![]() |
The factor 15/12 was used to calculate incorporation of the number two carbon of AcCoA. This was done by multiplying the measured incorporation of the number one carbon by 15/12, because 12 of the 27 carbons of cholesterol are from the number one carbon of AcCoA and 15 are from the number two carbon.
To calculate nmol substrate carbon incorporated into sterols from nmol AcCoA, a second correction factor that indicates the nmol substrate carbon/nmol AcCoA carbon was introduced into these calculations. Nanomoles of substrate can be converted directly to nmol of substrate carbon by multiplying the incorporation rates by the number of carbon atoms in each substrate that will ultimately form AcCoA. For acetate, butyrate, propionate, 3-hydroxybutyrate and citrate, the values calculated from the above equations were multiplied by 2/2, 4/2, 2/2, 4/2 and 2/2 nmol substrate carbon/nmol AcCoA carbon, respectively. CO2 production was calculated as previously described (19).
Statistical analysis.
Data are presented as means ± SEM. Differences were determined using paired t tests and ANOVA (two-way and repeated measures). When present, differences were identified using Tukeys Studentized range test. Differences were considered significant at P < 0.05. Computer programs were used to perform computations (41,42).
| RESULTS |
|---|
|
|
|---|
There was net synthesis of fatty acids by rat colonocytes as indicated by incorporation of 3H2O into all three classes of fatty acidcontaining lipids (Fig. 1). Rat colonocytes incorporated 9.15 ± 0.11 µmol 3H2O/(g dry wt · h) into fatty acids. Significantly more label (61%) was incorporated into phospholipid than into TAG or FFA. Similarly, significantly more 14C-acetate was incorporated into phospholipid than into FFA or TAG when cells were incubated with 14C-acetate.
|
Into both sterols and fatty acids, significantly more carbon was incorporated from acetate than from the other substrates that were evaluated in an equimolar mix of five substrates (Table 1). Incorporation of butyrate carbon was intermediate. Very small and significantly lower levels of carbon incorporation into sterols and fatty acids were observed from propionate, glucose and glutamine.
|
(-)-Hydroxycitrate concentrations from 0 to 7 mmol/L had no effect on CO2 production from [1-14C]butyrate in 5 mmol/L butyrate or on LDH leakage in isolated colonocytes (data not shown). Because there was no evidence of toxicity, (-)-hydroxycitrate was used at 7 mmol/L in all subsequent experiments to allow for maximal inhibition of citrate lyase. Under baseline conditions, the citrate lyase activity of cell preparations were 0.73 ± 0.01 µmol/(g dry wt · min). (-)-Hydroxycitrate at 7 mmol/L reduced the activity of colonocyte citrate lyase by 86.6 ± 0.96% (Fig. 2). Evidence that hydroxycitrate inhibited citrate lyase activity in intact colonocytes was provided by measuring oxidation and incorporation into lipids of exogenous citrate. Hydroxycitrate at 7 mmol/L had no influence on CO2 production from citrate but significantly reduced incorporation of citrate carbon into both cholesterol and fatty acids (Table 2).
|
|
Role of ketone bodies in the lipogenesis pathways of colonocytes.
To determine whether ketone bodies, acetate and butyrate form a common biosynthetic precursor pool for lipid synthesis, we evaluated the effects of ketone bodies on SCFA incorporation into lipids. Both 3-hydroxybutyrate and acetoacetate significantly suppressed incorporation of butyrate carbon into sterols and fatty acids and suppression was greater for acetoacetate than for 3-hydroxybutyrate (Fig. 3). 3-Hydroxybutyrate suppressed incorporation into sterol and fatty acids by 35 and 27%, respectively. Acetoacetate suppressed incorporation into sterols and fatty acids by 59 and 48%, respectively. By contrast, acetoacetate did not significantly suppress incorporation of acetate carbon into either sterols or fatty acids.
|
|
| DISCUSSION |
|---|
|
|
|---|
TCA cyclegenerated AcCoA does not appear to play a major role in providing precursors for lipid biosynthesis in colonic epithelial cells. As evidence, negligible incorporation into lipids was observed for glucose, glutamine and propionate, whereas incorporation was intermediate for butyrate and highest for acetate when cells were presented with an equimolar mixture of these substrates. By contrast, we observed previously that carbon dioxide production was greatest from butyrate, intermediate from glucose and glutamine, and least from acetate when assessed in colonocytes prepared using conditions identical to those of the present experiment (24). If TCA cycle entry followed by citrate efflux is the major route for AcCoA transport of precursor from the mitochondria to the cytosol for the purpose of lipid synthesis, one would expect that relative conversion of substrates to CO2 should be similar to relative incorporation into lipids. This was clearly not the case.
Evidence that the TCA cycle plays a minor role in providing precursors for lipid synthesis is provided also by experiments using hydroxycitrate, an inhibitor of cytosolic ATP-citrate lyase. Although we showed that hydroxycitrate effectively suppressed colonocyte citrate lyase and inhibited incorporation of citrate into sterols and fatty acids, hydroxycitrate did not suppress incorporation of either acetate or butyrate into sterols or fatty acids. If acetate- or butyrate-derived acetyl units were transported from the mitochondria to the cytosol predominantly via citrate, hydroxycitrate would be expected to suppress incorporation of acetate and/or butyrate carbon into lipids. This was not observed. Thus, the TCA cycle does not play a major role in providing synthetic precursors for lipogenesis in colonocytes. The lack of an effect by hydroxycitrate on acetate incorporation into lipids agrees well with observations in rat liver (33) and brain (32), where acetate may be activated in the cytosol. Although this might provide an explanation regarding the pathway by which acetate is incorporated into lipids in colonocytes, butyrate is not known to be activated in any compartment other than the mitochondria. In hepatocytes, hydroxycitrate prevents incorporation of butyrate carbon into fatty acids (34). Our data suggest that the transport of butyrate carbon via citrate occurs to a far lesser extent in colonocytes than in hepatocytes. A possible alternative to acetyl unit transport by citrate would be transfer via the ketone bodies.
Butyrate and ketone bodies appear to constitute a common precursor pool for lipid synthesis.
Carbon from 3-hydroxybutyrate was incorporated into sterols and fatty acids and incorporation of butyrate carbon into lipids was significantly decreased by both 3-hydroxybutyrate and acetoacetate. By contrast, acetoacetate did not suppress acetate incorporation into lipids. These results suggest that butyrate and ketone bodies contribute to a common synthetic precursor pool. The presence of mitochondrial HMG-CoA synthase in rat colonic mucosa was reported by others (43) and may be required for metabolism of SCFA to ketone bodies.
Cytosolic activation of acetate.
Acetate appears to be the preferred carbon source for lipogenesis in isolated colonocytes, because when present at equimolar concentrations together with several key substrates, acetate contributed more carbon to the synthesis of lipid than any other substrate tested. Butyrate carbon incorporation into lipid was suppressed by >50% when other substrates were available (Table 3), whereas acetate carbon incorporation into lipid was similar in the presence (Table 1) and absence (Fig. 3) of alternative substrates. In contrast, the metabolism of butyrate to CO2 was not influenced by the presence of alternative substrates, whereas the metabolism of acetate to CO2 was (24). This suggests important differences in the pathways and pools involved in metabolism of acetate and butyrate to CO2 vs. sterols and fatty acids.
Several observations support the suggestion that acetate and butyrate do not form a single, common, precursor pool for the synthesis of lipids. In previous studies, using protocols and mixtures of substrates comparable to those used in the present study, the ratio of acetate/butyrate for incorporation into CO2 was
1:8 (24). Also in colonocytes, incorporation into ketone bodies was found to be considerably lower from acetate than from butyrate [
1:10 (44)]. By contrast, the ratio of acetate/butyrate incorporation into lipids was
2:1 in this study. Because the acetate and butyrate molecules must be activated in the mitochondria to be metabolized to CO2 and ketone bodies, and because both CO2 and ketone bodies are produced from acetate to a far lesser extent than from butyrate when available simultaneously, acetate may be activated in the mitochondria to a considerably lower extent than butyrate. Our observation that acetate makes a larger contribution than butyrate to lipid synthesis can be explained only by invoking a second precursor pool to which acetate makes a major contribution. It is possible that incorporation of acetate into newly synthesized lipids relies on activation in both the cytosol and mitochondria of colonic epithelial cells as occurs in the liver (33) and brain (32).
Fatty acid classes.
The incorporation of 3H and 14C was greater into PL than into TAG and FFA. To a similar extent in colonic epithelium, much more lipid is present in PL than in either TAG or FFA (45). Unlike the enterocytes of the small intestine, colonocytes do not secrete lipoproteins, which may explain why the esterification of FFA to TAG was relatively small compared with the incorporation of FFA into PL. Due to the smaller 3H and 14C incorporation into TAG relative to PL, the main role of fatty acid synthesis in the colonocyte may be the provision of PL for membrane assembly.
In summary, these data suggest that colonocytes synthesize lipids in a manner that is distinct from that of other tissues such as liver. Unlike the liver, citrate transport does not appear to be very important in colonocytes. Butyrate and ketone bodies appear to form a common lipid synthetic precursor pool in colonocytes, suggesting that ketone bodies are a possible alternative for transport of acetyl units to the cytosol. Under the conditions evaluated, acetate and butyrate were the major carbon contributors to lipids in colonocytes and, although not directly tested, acetate may be activated to a great extent in the cytosol followed by direct incorporation into lipids. The high proportion of synthesized fatty acids found in phospholipid suggest that the major function of lipid synthesis in the epithelial cells of the colon is for membrane assembly.
| FOOTNOTES |
|---|
2 Supported by the Agriculture Experiment Station and the National Institutes of Health (AG-10765). ![]()
4 Abbreviations used: AcCoA, acetyl-CoA; FFA, free fatty acids; HMG-CoA, hydroxymethyl glutaryl CoA; LDH, lactate dehydrogenase; PL, phospholipid; TAG, triacylglyceride; TCA, tricarboxylic acid. ![]()
Manuscript received 13 May 2003. Initial review completed 7 July 2003. Revision accepted 20 August 2003.
| LITERATURE CITED |
|---|
|
|
|---|
1. Stange, E. F. & Dietschy, J. M. (1983) Cholesterol synthesis and low density lipoprotein uptake are regulated independently in rat small intestinal epithelium. Proc. Natl. Acad. Sci. U.S.A. 80:5739-5743.
2. Cerda, S. R., Wilkinson, J. T., Branch, S. K. & Broitman, S. A. (1999) Enhancement of sterol synthesis by the monoterpene perillyl alcohol is unaffected by competitive 3-hydroxy-3-methylglutaryl-CoA reductase inhibition. Lipids 34:605-615.[Medline]
3. Herold, G., Jungwirth, R., Rogler, G., Geerling, I. & Stange, E. F. (1995) Influence of cholesterol supply on cell growth and differentiation in cultured enterocytes (Caco-2). Digestion 56:57-66.[Medline]
4. Wachtershauser, A., Akoglu, B. & Stein, J. (2001) HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2. Carcinogenesis 22:1061-1067.
5. Narisawa, T., Fukaura, Y., Terada, K., Umezawa, A., Tanida, N., Yazawa, K. & Ishikawa, C. (1994) Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice. Carcinogenesis 15:2045-2048.
6. Narisawa, T., Fukaura, Y., Tanida, N., Hasebe, M., Ito, M. & Aizawa, R. (1996) Chemopreventive efficacy of low dose of pravastatin, an HMG-CoA reductase inhibitor, on 1,2-dimethylhydrazine-induced colon carcinogenesis in ICR mice. Tohoku J. Exp. Med. 180:131-138.[Medline]
7. Narisawa, T., Morotomi, M., Fukaura, Y., Hasebe, M., Ito, M. & Aizawa, R. (1996) Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats. Jpn. J. Cancer Res. 87:798-804.[Medline]
8. Kendall, C. W., Janezic, S. A., Friday, D. & Rao, A. V. (1992) Dietary cholesterol enhances preneoplastic aberrant crypt formation and alters cell proliferation in the murine colon treated with azoxymethane. Nutr. Cancer 17:107-114.[Medline]
9. Hori, T., Matsumoto, K., Sakaitani, Y., Sato, M. & Morotomi, M. (1998) Effect of dietary deoxycholic acid and cholesterol on fecal steroid concentration and its impact on the colonic crypt cell proliferation in azoxymethane-treated rats. Cancer Lett. 124:79-84.[Medline]
10. Dietschy, J. M. & Siperstein, M. D. (1965) Cholesterol synthesis by the gastrointestinal tract: localization and mechanisms of control. J. Clin. Investig. 44:1311-1327.
11. Spady, D. K. & Dietschy, J. M. (1983) Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat. J. Lipid Res. 24:303-315.[Abstract]
12. Roediger, W. E., Kapaniris, O. & Millard, S. (1992) Lipogenesis from n-butyrate in colonocytes. Action of reducing agent and 5-aminosalicylic acid with relevance to ulcerative colitis. Mol. Cell. Biochem. 118:113-118.[Medline]
13. Leschelle, X., Delpal, S., Goubern, M., Blottiere, H. M. & Blachier, F. (2000) Butyrate metabolism upstream and downstream of acetyl-CoA synthesis and growth control of human colon carcinoma cells. Eur. J. Biochem. 267:6435-6442.[Medline]
14. Marcil, V., Delvin, E., Seidman, E., Poitras, L., Zoltowska, M., Garofalo, C. & Levy, E. (2002) Modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein assembly by butyrate. Am. J. Physiol. 283:G340-G346.
15. Nazih, H., Nazih-Sanderson, F., Krempf, M., Michel Huvelin, J., Mercier, S. & Marie Bard, J. (2001) Butyrate stimulates ApoA-IV-containing lipoprotein secretion in differentiated Caco-2 cells: role in cholesterol efflux. J. Cell. Biochem. 83:230-238.[Medline]
16. Bergman, E. N. (1990) Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol. Rev. 70:567-590.
17. Roediger, W. E. (1980) Anaerobic bacteria, the colon and colitis. Aust. N.Z. J. Surg. 50:73-75.[Medline]
18. Roediger, W. E. (1982) Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83:424-429.[Medline]
19. Fleming, S. E., Fitch, M. D., DeVries, S., Liu, M. L. & Kight, C. (1991) Nutrient utilization by cells isolated from rat jejunum, cecum and colon. J. Nutr. 121:869-878.
20. Anonymous, (1995) Nutrient Requirements of Laboratory Animals 4th rev. ed. 1995 National Academy Press Washington, DC.
21. Lowenstein, J. M. & Brunengraber, H. (1981) Hydroxycitrate. Methods Enzymol. 72:486-497.[Medline]
22. Lewis, Y. S. (1969) Isolation and properties of hydroxycitric acid. Methods. Enzymol. 13:613-619.
23. Fleming, S. E. & Kight, C. E. (1994) The TCA cycle as an oxidative and synthetic pathway is suppressed with aging in jejunal epithelial cells. Can. J. Physiol. Pharmacol. 72:266-274.[Medline]
24. Fleming, S. E. & Gill, R. (1997) Aging stimulates fatty acid oxidation in rat colonocytes but does not influence the response to dietary fiber. J. Gerontol. A. Biol. Sci. Med. Sci. 52:B318-B330.[Abstract]
25. Fleming, S. E., Fitch, M. D. & Hudes, M. (1994) Intestinal cell respiration is influenced by animal age, strain, and feeding status. J. Gerontol. 49:B22-B30.[Medline]
26. Clausen, M. R. & Mortensen, P. B. (1995) Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut 37:684-689.
27. Darcy-Vrillon, B., Cherbuy, C., Morel, M. T., Durand, M. & Duee, P. H. (1996) Short chain fatty acid and glucose metabolism in isolated pig colonocytes: modulation by NH4+. Mol. Cell. Biochem. 156:145-151.[Medline]
28. Kight, C. E. & Fleming, S. E. (1993) Nutrient oxidation by rat intestinal epithelial cells is concentration dependent. J. Nutr. 123:876-882.
29. Kobayashi, H. & Fleming, S. (2001) The source of dietary fiber influences short-chain fatty acid production and concentrations in the large bowel. Spiller, G. eds. CRC Handbook of Dietary Fiber in Human Nutrition 3rd ed. 2001:287-315 CRC Press Boca Raton, FL. .
30. Windmueller, H. G. & Spaeth, A. E. (1980) Respiratory fuels and nitrogen metabolism in vivo in small intestine of fed rats 1980 Quantitative importance of glutamine glutamate, and aspartate. J. Biol. Chem. 255 107112.
31. Watson, J. A., Fang, M. & Lowenstein, J. M. (1969) Tricarballylate and hydroxycitrate: substrate and inhibitor of ATP: citrate oxaloacetate lyase. Arch. Biochem. Biophys. 135:209-217.[Medline]
32. Patel, M. S. & Owen, O. E. (1976) Lipogenesis from ketone bodies in rat brain. Evidence for conversion of acetoacetate into acetyl-coenzyme A in the cytosol. Biochem. J. 156:603-607.[Medline]
33. Watson, J. A. & Lowenstein, J. M. (1970) Citrate and the conversion of carbohydrate into fat. Fatty acid synthesis by a combination of cytoplasm and mitochondria. J. Biol. Chem. 245:5993-6002.
34. Crabtree, B., Souter, M. J. & Anderson, S. E. (1989) Evidence that the production of acetate in rat hepatocytes is a predominantly cytoplasmic process. Biochem. J. 257:673-678.[Medline]
35. Pullinger, C. R. & Gibbons, G. F. (1983) The role of substrate supply in the regulation of cholesterol biosynthesis in rat hepatocytes. Biochem. J. 210:625-632.[Medline]
36. Sullivan, A. C., Hamilton, J. G., Miller, O. N. & Wheatley, V. R. (1972) Inhibition of lipogenesis in rat liver by (-)-hydroxycitrate. Arch. Biochem. Biophys. 150:183-190.[Medline]
37. Brunengraber, H., Sabine, J. R., Boutry, M. & Lowenstein, J. M. (1972) 3(-)-Hydroxysterol synthesis by the liver. Arch. Biochem. Biophys. 150:392-396.[Medline]
38. Srere, P. A. (1959) The citrate cleavage enzyme. I. Distribution and purification. J. Biol. Chem. 234:2544-2547.
39. Bligh, E. G. & Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
40. Levin, M. S., Talkad, V. D., Gordon, J. I. & Stenson, W. F. (1992) Trafficking of exogenous fatty acids within Caco-2 cells. J. Lipid Res. 33:9-19.[Abstract]
41. Microsoft (1995) Excel 1995 Microsoft Seattle, WA.
42. SPSS (1986) SPSSX Users Guide 2nd ed. 1986 SPSS Chicago, IL.
43. Cherbuy, C., Darcy-Vrillon, B., Morel, M. T., Pegorier, J. P. & Duee, P. H. (1995) Effect of germfree state on the capacities of isolated rat colonocytes to metabolize n-butyrate, glucose, and glutamine. Gastroenterology 109:1890-1899.[Medline]
44. Cremin, J. D., Jr, Fitch, M. D. & Fleming, S. E. (2003) Glucose alleviates ammonia-induced inhibition of short-chain fatty acid metabolism in rat colonic epithelial cells. Am. J. Physiol. 285:G105-G114.
45. Ruiz-Gutierrez, V., Vazquez, C. M. & Quintero, F. J. (1994) Effect of intestinal resection on phospholipid class distribution and fatty acid composition of mucosal cells in the rat large intestine. J. Biochem. 115:32-36.
This article has been cited by other articles:
![]() |
G. D'Argenio, M. Calvani, A. Casamassimi, O. Petillo, S. Margarucci, M. Rienzo, I. Peluso, R. Calvani, A. Ciccodicola, N. Caporaso, et al. Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine-loaded liposomes FASEB J, December 1, 2006; 20(14): 2544 - 2546. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Doughty, B. F. Bleiman, D. J. Wagner, F. J. Dufort, J. M. Mataraza, M. F. Roberts, and T. C. Chiles Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth Blood, June 1, 2006; 107(11): 4458 - 4465. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||